Stay updated with breaking news from Devgn sir. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Stock analysts at StockNews.com initiated coverage on shares of Evogene (NASDAQ:EVGN – Get Free Report) in a research report issued to clients and investors on Monday. The firm set a “sell” rating on the biotechnology company’s stock. Several other equities analysts also recently weighed in on the stock. Roth Mkm lifted their price target on […] ....
By Colin Kellaher Evogene Ltd. on Monday said its Lavie Bio unit has signed a licensing agreement granting seed and pesticide maker Corteva exclusive rights. ....
By Colin Kellaher Shares of Evogene Ltd. fell sharply on Monday after the computational biology company said it was raising $8.5 million in a dilutive. ....
Evogene Ltd. (NASDAQ:EVGN – Get Rating)’s stock price crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $0.68 and traded as low as $0.61. Evogene shares last traded at $0.65, with a volume of 132,598 shares. Analyst Upgrades and Downgrades Separately, […] ....
Ahmedabad, June 4: Vash , the Gujarati supernatural horror thriller film, is all set for a Hindi remake helmed by Queem director Vikas Bahl and Ajay Devgn, who s also the producer along with Kumar Mangat, playing the lead. ....